試す 金 - 無料
Autopay chaos in sight as @paytm nears 31 Aug end
Mint Mumbai
|August 14, 2025
Come 1 September, and thousands of autopay transactions for insurance premiums and Netflix subscriptions may fail, as a hard deadline to discontinue the @paytm handle for UPI payments kicks in.
As part of a series of measures against Paytm Payments Bank last year, the Reserve Bank of India (RBI) curbed the use of the @paytm UPI handle. Following this, the National Payments Corp. of India (NPCI) mandated migrating these handles to other banks. However, multiple old handles remain tied to autopay mandates, putting these planned transactions at risk once the deadline is crossed, two people familiar with the matter said.
"Users will have to first cancel the existing mandate linked to the @paytm handle and then create a fresh one with their new handles. There has to be a greater push for users to do that," said an insurance industry executive said on the condition of anonymity. Despite repeated reminders, many customers have not migrated yet, the executive added.
Emails sent to the Reserve Bank of India, NPCI and Paytm remained unanswered.
On 31 January 2024, RBI barred any addition of funds to Paytm Payments Bank accounts, wallets and Fastags. In February 2024, RBI said that @paytm UPI handles should be migrated to a different clutch of banks and that the payments bank will not be allowed to undertake any transactions post 15 March.
このストーリーは、Mint Mumbai の August 14, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Mumbai からのその他のストーリー
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

